Trevi Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing the investigational therapy Haduviotm (oral nalbuphine ER) for the treatment of chronic cough in patients with ...

Trevi Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing the investigational therapy Haduviotm (oral nalbuphine ER) for the treatment of chronic cough in patients with ...

Ahmedabad: Pharma major, Zydus Lifesciences Limited, has received tentative approval from the United States Food and Drug ...

The presentation was designed to help social workers and other clinicians better understand and respond to the opioid epidemic for the benefit of patients and their families. Naturally or ...

Safe Yakima Valley is reporting another spike in overdoses, with 11 new overdoses reported across Yakima County in the last ...

This story was originally published by Mountain State Spotlight. Get stories like this delivered to your email inbox once a ...

While mu opioid receptor (MOR) agonists are especially effective as ... Recently, many groups have sought MOR agonists that induce minimal βarrestin-mediated signaling because MOR agonist-treated ...

NLS Pharmaceutics Ltd. (NASDAQ: NLSP), a Swiss clinical-stage biopharmaceutical company focused on central nervous system ...

Ferris said recent efforts to increase the number of physicians prescribing Opioid Agonist Therapy medications, and improved access to these therapies in rural, remote and Indigenous communities, are ...

Ferris said recent efforts to increase the number of physicians prescribing Opioid Agonist Therapy medications, and improved access to these therapies in rural, remote and Indigenous communities ...